OpenScience.ink

Hot New Top

6 days ago • Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Ongoing Challenges in Treating Hard-to-Treat Depression After Ketamine's Initial EffectsTreatment-resistant Depression in the Post-ketamine Era: Unmet Needs beyond Rapid Response.

📖 Top 20% JournalArticle

1 week ago • Trends in psychiatry and psychotherapy

Testing if ibogaine is safe and helpful for people with moderate to severe alcohol addictionFeasibility, safety and preliminary effects of ibogaine in patients with moderate and severe alcohol use disorder: a pilot, open-label study.

📖 Top 30% JournalArticle

1 week ago • Analytical and bioanalytical chemistry

Sensitive test using glowing particles to detect mescaline and LSD in hair samplesHigh-sensitivity immunochromatographic assay based on time-resolved fluorescence microspheres for the simultaneous detection of mescaline and LSD in hair.

📖 Top 30% JournalArticle

1 week ago • L'Encephale

Use of classic psychedelics and links to suicidal thoughts and behaviors: A review of research[Illicit use of classic psychedelics and suicidality: A systematic literature review].

📖 Top 50% JournalEnglish Abstract

1 week ago • Psychiatric research and clinical practice

Real-World Benefits and Costs of Nasal Esketamine Compared to Muscle-Injected KetamineReal-World Effectiveness and Cost-Differential of Intranasal Esketamine Versus Intramuscular Ketamine.

📖 Top 20% Journal

1 week ago • Journal of neuroimmunology

S-ketamine and S-HNK quickly reduce depression-like behavior by targeting inflammation pathways in the thinking areas of the brainTargeting TLR4/PPARα-mediated neuroinflammation in the prefrontal cortex: S-ketamine and S-HNK rapidly alleviate depression-like behaviors.

📖 Top 20% Journal

3 weeks ago • Pain management

Combining high-dose ketamine, psychological support, and specialized pain care for hard-to-treat pain conditionsInnovative integration of high dose ketamine infusion, psychological services, and specialized multidisciplinary pain care for refractory pain syndromes.

📖 Top 50% Journal

1 week ago • Journal of music therapy

Participants’ Music Experiences During Psychedelic Therapy for Life-Threatening IllnessParticipants' Music Experiences Associated With Psychedelic-Assisted Psychotherapy for Life-Threatening Illness: Interpretivist Research.

Randomized Controlled Trial

5 days ago • Journal of military, veteran and family health

Review of a psychiatric outpatient therapy program using ketamine across different diagnosesA retrospective report of a ketamine-augmented, transdiagnostic psychiatric outpatient psychotherapy program.

📖 Top 50% JournalArticle

3 weeks ago • Journal of medical case reports

Changes in Dream Content and Dissociation Feelings During Ketamine Treatment for Chronic Low Back Pain: A Case ReportLongitudinal dream-content shift and void-like dissociative phenomenology around outpatient ketamine infusions in chronic low back pain: a case report.

3 weeks ago • Antonie van Leeuwenhoek

First molecular identification of the mushroom Panaeolus subbalteatus in PakistanFirst molecular record of Panaeolus subbalteatus (Psathyrellaceae, Agaricales) from Pakistan.

📖 Top 50% Journal

3 weeks ago • Fa yi xue za zhi

Recent Advances in Understanding Mescaline and Similar Compounds[Research Progress on Mescaline and Its Analogues].

4 weeks ago • BMJ case reports

Long-term ketamine use linked to worsening problems in multiple organsChronic ketamine use associated with progressive multisystem organ dysfunction.

2 weeks ago • bioRxiv : the preprint server for biology

Psilocybin may improve thinking flexibility affected by abnormal error signals in decision-making areasPsilocybin selectively rescues cognitive flexibility impairments caused by aberrant prefrontal error signaling.

3 weeks ago • Npj mental health research

Personality changes after first psychedelic use in German college studentsPersonality changes following first-time psychedelic use in college students in Germany.

4 days ago • bioRxiv : the preprint server for biology

"Dark magic mushroom" produces both deadly toxins and psychedelic compoundsThe "dark magic mushroom" co-produces amatoxins and psilocybin.

Preprint

4 days ago • bioRxiv : the preprint server for biology

Psychedelic drugs affect nerve cell branches differently depending on behavior and serotonin receptorsPsychedelic drug action at dendrites is gated by behavioral state and serotonin receptors.

Preprint

1 week ago • Progress in neuro-psychopharmacology & biological psychiatry

MDMA as an early treatment after trauma in an animal model of PTSDMDMA as an early post-trauma intervention in a translational animal model of PTSD.

3 weeks ago • Journal of psychopharmacology (Oxford, England)

DMT may improve anxiety, life satisfaction, and quality of life in healthy people and those with depression beyond just reducing symptomsBeyond symptom reduction: DMT improves anxiety, life satisfaction, and quality of life in healthy volunteers and patients with depression.

1 week ago • Journal of psychopharmacology (Oxford, England)

No signs of harmful effects of psilocybin and MDMA on working memory or brain activity in healthy adultsNo evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory study.

3 weeks ago • Journal of psychopharmacology (Oxford, England)

Using timed drug treatments to improve brain adaptability for depression and other nervous system disordersEnhancing plasticity to treat depression and other central nervous system diseases using event-driven pharmacology.

3 weeks ago • Annals of medicine and surgery (2012)

Psilocybin therapy for hard-to-treat depression: quick recovery, unclear lasting effects, and future research stepsPsilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidence.

4 days ago • bioRxiv : the preprint server for biology

Psilocybin unevenly changes decision-making and brain processing when outcomes are uncertainPsilocybin asymmetrically modulates outcome-based choice and cortical processing under uncertainty.

Preprint

6 days ago • medRxiv : the preprint server for health sciences

Psilocybin with early palliative care for feelings of hopelessness and long-term pain: a preliminary open studyPsilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study.

Preprint

2 days ago • The Psychiatric clinics of North America

Building Skills with Psychedelic Therapy While Addressing Social Health FactorsCapacity Building Through Psychedelic-Assisted Therapy: Navigating Social Determinants of Health.

Article

2 days ago • Journal of psychopharmacology (Oxford, England)

Finding the best dose for psychedelics to reduce fear in rodent studiesWhere is the sweet spot for psychedelic-enhanced fear extinction? An integrative quantitative synthesis of dose-effect patterns in rodent models.

Article

2 days ago • Journal of pain and symptom management

Safety and Effectiveness of Psilocybin During Cancer Treatment: Analysis of a Phase II TrialSafety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis.

Article

4 days ago • Psychedelic medicine (New Rochelle, N.Y.)

How Canadian Veterans Find and View Psychedelic Treatments: Routes and ChallengesExploring Access to Psychedelics Among Canadian Veterans: Pathways, Barriers, and Perceptions.

Article

4 days ago • Psychedelic medicine (New Rochelle, N.Y.)

Psychiatrists' Preparedness to Use Psilocybin in Treatment in Louisiana, a State with Little Psychedelic ResearchAssessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.

Article

4 days ago • Focus (American Psychiatric Publishing)

New Uses of Ketamine and Esketamine for Treating Mental Health DisordersEmerging Clinical Applications of Ketamine and Esketamine Across Psychiatric Disorders.

Article

← prevpage 3 of 4next →

Psychedelic Science Research Papers